Related Experiment Video
Updated: May 15, 2026
09:02
Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment
Published on: June 28, 2018
Stem cell therapy in chronic obstructive pulmonary disease. Seeking the Prometheus effect
Argyris Tzouvelekis1, Geoff Laurent, Demosthenes Bouros
1Department of Pneumonology, University Hospital of Alexandroupolis, Medical School, Democritus University of Thrace, Alexandroupolis 68100, Greece. atzouvelekis@yahoo.gr
Current Drug Targets
|December 22, 2012
Summary
Stem cell therapy shows promise for chronic obstructive pulmonary disease (COPD) by targeting lung inflammation and damage. However, safety concerns and a lack of understanding regarding stem cell behavior in COPD patients necessitate further research and careful clinical trial design.
Area of Science:
- Pulmonary Medicine
- Regenerative Medicine
- Cell Biology
Background:
- Chronic obstructive pulmonary disease (COPD) involves lung structural changes, inflammation, cell death, and tissue breakdown.
- Systemic inflammation in COPD contributes to severe comorbidities.
- Current COPD treatments are inadequate, highlighting the need for novel therapeutic strategies.
Purpose of the Study:
- To explore the potential of stem cell therapy for COPD.
- To address the unmet need for treatments that modulate local and systemic inflammation and promote tissue repair.
- To investigate the safety and efficacy of stem cell applications in COPD.
Main Methods:
- Review of existing research on stem cell properties and applications in COPD.
- Analysis of experimental data and early clinical trial outcomes.
- Identification of knowledge gaps concerning stem cell fate and mechanisms in the COPD lung.
Main Results:
- Stem cell therapy is a promising approach for COPD due to its regenerative potential.
- Clinical application is hindered by safety concerns and limited understanding of stem cell behavior in COPD.
- Initial clinical trials have yielded disappointing results, emphasizing the need for caution.
Conclusions:
- Further research is crucial to understand stem cell mechanisms and safety in COPD.
- Careful study design with realistic goals and appropriate biomarkers is essential for evaluating stem cell therapy efficacy.
- More investigation is needed before stem cell therapy can be widely adopted for COPD treatment.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...